STAT3 and colorectal carcinoma: The miR-181a-5p carried by EVs derived from highly metastatic CRC cells could activate hepatic stellate cells (HSCs) by targeting SOCS3 and activating the IL6/STAT3 signaling, leading to TME reprogramming and PMN formation, thereby promoting liver metastasis of CRC [75].